Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Grey Wolf To Use £10m Series A To Illuminate Tumors For Destruction

Feb 11 2019

• By Sten Stovall

CancerSlide — Grey Wolf To increase cancer visibility By modulating ERAP1 activity. • Source: Shutterstock

Additional Topics

Financing ImmunoOncology Commercial Companies Cancer BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.